The hormone insulin plays a central role in the metabolism of many living organisms. When food is plentiful, insulin promotes ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

Dr. Jaishree Sharad talks about how one should limit the use of sugar rather than cheating themselves by having so-called ...

A high-sugar diet may increase the risk of weight gain, obesity, cancer, and potentially accelerate tumor growth.

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.

With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth.

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

Global growth is projected at 3.3 percent both in 2025 and 2026, below the historical (2000–19) average of 3.7 percent. The forecast for 2025 is broadly unchanged from that in the October 2024 World ...

Insulin-like growth factor 1 (IGF-1) is a hormone important for cell development and reducing programmed cell death. This hormone also plays a role in the progression and metastasis of cancer.

Producer prices have been in negative territory for more than two years, and consumer prices managed growth of just 0.1 per cent in December. Some content could not load. Check your internet ...